1. Home
  2. COLL vs ARRY Comparison

COLL vs ARRY Comparison

Compare COLL & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • ARRY
  • Stock Information
  • Founded
  • COLL 2002
  • ARRY 1989
  • Country
  • COLL United States
  • ARRY United States
  • Employees
  • COLL N/A
  • ARRY N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • ARRY Semiconductors
  • Sector
  • COLL Health Care
  • ARRY Technology
  • Exchange
  • COLL Nasdaq
  • ARRY Nasdaq
  • Market Cap
  • COLL 910.2M
  • ARRY 1.1B
  • IPO Year
  • COLL 2015
  • ARRY 2020
  • Fundamental
  • Price
  • COLL $29.05
  • ARRY $4.43
  • Analyst Decision
  • COLL Strong Buy
  • ARRY Buy
  • Analyst Count
  • COLL 5
  • ARRY 21
  • Target Price
  • COLL $43.60
  • ARRY $9.87
  • AVG Volume (30 Days)
  • COLL 438.9K
  • ARRY 4.4M
  • Earning Date
  • COLL 05-08-2025
  • ARRY 05-08-2025
  • Dividend Yield
  • COLL N/A
  • ARRY N/A
  • EPS Growth
  • COLL 43.56
  • ARRY N/A
  • EPS
  • COLL 1.86
  • ARRY N/A
  • Revenue
  • COLL $631,449,000.00
  • ARRY $915,807,000.00
  • Revenue This Year
  • COLL $20.00
  • ARRY $22.08
  • Revenue Next Year
  • COLL $3.93
  • ARRY $12.88
  • P/E Ratio
  • COLL $15.63
  • ARRY N/A
  • Revenue Growth
  • COLL 11.41
  • ARRY N/A
  • 52 Week Low
  • COLL $27.28
  • ARRY $4.35
  • 52 Week High
  • COLL $42.29
  • ARRY $14.95
  • Technical
  • Relative Strength Index (RSI)
  • COLL 43.65
  • ARRY 27.64
  • Support Level
  • COLL $29.01
  • ARRY $4.61
  • Resistance Level
  • COLL $30.53
  • ARRY $4.98
  • Average True Range (ATR)
  • COLL 0.88
  • ARRY 0.32
  • MACD
  • COLL -0.01
  • ARRY -0.09
  • Stochastic Oscillator
  • COLL 20.97
  • ARRY 4.28

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Its operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

Share on Social Networks: